We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
BridgeBio Pharma
BBIO
$16.4B
| $4.81M | 0.03% |
630,711
-190,350
| -23% | -$1.82M |
|
652
Diamondrock Hospitality Co
DRH
$2.5B
| $4.8M | 0.03% |
586,320
-191,103
| -25% | -$1.66M |
|
653
Procept Biorobotics
PRCT
$1.22B
| $4.8M | 0.03% |
115,490
-28,750
| -20% | -$1.23M |
|
654
Oceaneering
OII
$5.08B
| $4.79M | 0.03% |
+274,140
| New | +$3.64M |
|
|
RVNC
655
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.79M | 0.03% |
259,453
-289,154
| -53% | -$6.61M |
|
656
Canadian National Railway
CNI
$76.4B
| $4.78M | 0.03% |
40,219
+8,223
| +26% | +$983K |
|
657
Willis Towers Watson
WTW
$31.6B
| $4.78M | 0.03% |
+19,529
| New | +$4.46M |
|
658
Century Communities
CCS
$2B
| $4.74M | 0.03% |
94,871
-33,961
| -26% | -$1.61M |
|
659
Walker & Dunlop
WD
$1.45B
| $4.74M | 0.03% |
60,418
+4,534
| +8% | +$381K |
|
660
Mine Safety
MSA
$7.41B
| $4.74M | 0.03% |
32,884
-9,336
| -22% | -$1.22M |
|
661
ACI Worldwide
ACIW
$5.33B
| $4.74M | 0.03% |
+205,993
| New | +$4.44M |
|
662
Manhattan Associates
MANH
$11.2B
| $4.73M | 0.03% |
+38,997
| New | +$4.79M |
|
663
BorgWarner
BWA
$14B
| $4.72M | 0.03% |
133,127
+56,122
| +73% | +$1.91M |
|
664
MetLife
MET
$61.4B
| $4.68M | 0.03% |
+64,727
| New | +$4.64M |
|
665
dLocal
DLO
$4.2B
| $4.66M | 0.03% |
+299,524
| New | +$5.27M |
|
666
RELX
RELX
$60.2B
| $4.66M | 0.03% |
168,125
-147,391
| -47% | -$3.97M |
|
667
KT
KT
$8.83B
| $4.63M | 0.03% |
343,285
+142,899
| +71% | +$1.9M |
|
|
DICE
668
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $4.62M | 0.03% |
+148,194
| New | +$4.83M |
|
669
Health Catalyst
HCAT
$135M
| $4.6M | 0.03% |
432,889
+173,490
| +67% | +$1.67M |
|
670
Fox Class B
FOX
$23.5B
| $4.59M | 0.03% |
161,165
+20,005
| +14% | +$573K |
|
671
Carnival Corporation Ltd
CCL
$37.9B
| $4.57M | 0.03% |
+567,049
| New | +$4.89M |
|
672
DuPont de Nemours
DD
$19.5B
| $4.56M | 0.03% |
+52,879
| New | +$4.22M |
|
673
Century Aluminum
CENX
$4.77B
| $4.54M | 0.03% |
555,009
-300,249
| -35% | -$2.27M |
|
674
News Corp Class A
NWSA
$15.5B
| $4.53M | 0.03% |
248,888
-860,926
| -78% | -$15M |
|
675
STAAR Surgical
STAA
$1.27B
| $4.52M | 0.03% |
93,111
-22,123
| -19% | -$1.39M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.